316 related articles for article (PubMed ID: 36959810)
1. The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges.
Hu Q; Li K; Yang C; Wang Y; Huang R; Gu M; Xiao Y; Huang Y; Chen L
Front Oncol; 2023; 13():1133164. PubMed ID: 36959810
[TBL] [Abstract][Full Text] [Related]
2. Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives.
Chetan MR; Gleeson FV
Eur Radiol; 2021 Feb; 31(2):1049-1058. PubMed ID: 32809167
[TBL] [Abstract][Full Text] [Related]
3. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study.
Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
Front Immunol; 2022; 13():859323. PubMed ID: 35572597
[TBL] [Abstract][Full Text] [Related]
4. PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review.
Urso L; Manco L; Castello A; Evangelista L; Guidi G; Castellani M; Florimonte L; Cittanti C; Turra A; Panareo S
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362190
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC.
Keek SA; Kayan E; Chatterjee A; Belderbos JSA; Bootsma G; van den Borne B; Dingemans AC; Gietema HA; Groen HJM; Herder J; Pitz C; Praag J; De Ruysscher D; Schoenmaekers J; Smit HJM; Stigt J; Westenend M; Zeng H; Woodruff HC; Lambin P; Hendriks L
Ther Adv Med Oncol; 2022; 14():17588359221116605. PubMed ID: 36032350
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. A subregion-based positron emission tomography/computed tomography (PET/CT) radiomics model for the classification of non-small cell lung cancer histopathological subtypes.
Shen H; Chen L; Liu K; Zhao K; Li J; Yu L; Ye H; Zhu W
Quant Imaging Med Surg; 2021 Jul; 11(7):2918-2932. PubMed ID: 34249623
[TBL] [Abstract][Full Text] [Related]
8. Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.
Abdurixiti M; Nijiati M; Shen R; Ya Q; Abuduxiku N; Nijiati M
Br J Radiol; 2021 Jun; 94(1122):20201272. PubMed ID: 33882244
[TBL] [Abstract][Full Text] [Related]
9. Overall Survival Prognostic Modelling of Non-small Cell Lung Cancer Patients Using Positron Emission Tomography/Computed Tomography Harmonised Radiomics Features: The Quest for the Optimal Machine Learning Algorithm.
Amini M; Hajianfar G; Hadadi Avval A; Nazari M; Deevband MR; Oveisi M; Shiri I; Zaidi H
Clin Oncol (R Coll Radiol); 2022 Feb; 34(2):114-127. PubMed ID: 34872823
[TBL] [Abstract][Full Text] [Related]
10. A PET/CT nomogram incorporating SUVmax and CT radiomics for preoperative nodal staging in non-small cell lung cancer.
Xie Y; Zhao H; Guo Y; Meng F; Liu X; Zhang Y; Huai X; Wong Q; Fu Y; Zhang H
Eur Radiol; 2021 Aug; 31(8):6030-6038. PubMed ID: 33560457
[TBL] [Abstract][Full Text] [Related]
11. Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics.
van Timmeren JE; Carvalho S; Leijenaar RTH; Troost EGC; van Elmpt W; de Ruysscher D; Muratet JP; Denis F; Schimek-Jasch T; Nestle U; Jochems A; Woodruff HC; Oberije C; Lambin P
PLoS One; 2019; 14(6):e0217536. PubMed ID: 31158263
[TBL] [Abstract][Full Text] [Related]
12. Radiomics in PET/CT: Current Status and Future AI-Based Evolutions.
Hatt M; Cheze Le Rest C; Antonorsi N; Tixier F; Tankyevych O; Jaouen V; Lucia F; Bourbonne V; Schick U; Badic B; Visvikis D
Semin Nucl Med; 2021 Mar; 51(2):126-133. PubMed ID: 33509369
[TBL] [Abstract][Full Text] [Related]
13. Performance of
Zhang M; Bao Y; Rui W; Shangguan C; Liu J; Xu J; Lin X; Zhang M; Huang X; Zhou Y; Qu Q; Meng H; Qian D; Li B
Front Oncol; 2020; 10():568857. PubMed ID: 33134170
[TBL] [Abstract][Full Text] [Related]
14. [
Manafi-Farid R; Askari E; Shiri I; Pirich C; Asadi M; Khateri M; Zaidi H; Beheshti M
Semin Nucl Med; 2022 Nov; 52(6):759-780. PubMed ID: 35717201
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis.
Bedrikovetski S; Dudi-Venkata NN; Kroon HM; Seow W; Vather R; Carneiro G; Moore JW; Sammour T
BMC Cancer; 2021 Sep; 21(1):1058. PubMed ID: 34565338
[TBL] [Abstract][Full Text] [Related]
16. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [
Zhao X; Zhao Y; Zhang J; Zhang Z; Liu L; Zhao X
EJNMMI Res; 2023 Jan; 13(1):4. PubMed ID: 36682020
[TBL] [Abstract][Full Text] [Related]
17. PET/CT radiomics in breast cancer: Mind the step.
Sollini M; Cozzi L; Ninatti G; Antunovic L; Cavinato L; Chiti A; Kirienko M
Methods; 2021 Apr; 188():122-132. PubMed ID: 31978538
[TBL] [Abstract][Full Text] [Related]
18. 2-[
Manafi-Farid R; Karamzade-Ziarati N; Vali R; Mottaghy FM; Beheshti M
Methods; 2021 Apr; 188():84-97. PubMed ID: 32497604
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence in immunotherapy PET/SPECT imaging.
McGale JP; Chen DL; Trebeschi S; Farwell MD; Wu AM; Cutler CS; Schwartz LH; Dercle L
Eur Radiol; 2024 Feb; ():. PubMed ID: 38355986
[TBL] [Abstract][Full Text] [Related]
20. Multiblock Discriminant Analysis of Integrative
Lee SH; Kao GD; Feigenberg SJ; Dorsey JF; Frick MA; Jean-Baptiste S; Uche CZ; Cengel KA; Levin WP; Berman AT; Aggarwal C; Fan Y; Xiao Y
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1451-1465. PubMed ID: 33662459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
